| Description |
1 online resource : illustrations |
| Series |
SAGE Knowledge. Cases |
|
SAGE Knowledge. Cases
|
| Summary |
The case explains how and why Thalidomide was at last licensed by the FDA and how this would benefit the manufacturer of the drug Celgene |
| Notes |
Originally published in Diermeier, D., Hermitage, J., Thaker, S., & Heinze, J. (2006). Reintroduce thalidomide? (B). 5-104-003(B). Evanston, IL: Kellogg School of Management at Northwestern University |
|
Description based on XML content |
| Subject |
United States. Food and Drug Administration.
|
|
Immunopharmacology.
|
|
Thalidomide.
|
| Form |
Electronic book
|
| Author |
Hermitage, Jason, author
|
|
Thaker, Shail, author
|
|
Heinze, Justin, author
|
| ISBN |
9781526449818 (ebook) |
|
